Inhibikase Therapeutics Prices $4.0M Registered Direct Offering And Warrant Inducement Of 1,672,452 Shares Of Common Stock And 1,672,452 Unregisted Class B Warrants At Combined Purchase Price Of $1.68 Per Common Stock And Series A And B Warrant.
$IKT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Inhibikase Therapeutics Prices $4.0M Registered Direct Offering And Warrant Inducement Of 1,672,452 Shares Of Common Stock And 1,672,452 Unregisted Class B Warrants At Combined Purchase Price Of $1.68 Per Common Stock And Series A And B Warrant.